{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T17:27:01Z","timestamp":1767893221979,"version":"3.49.0"},"reference-count":55,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0068969","type":"journal-article","created":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T21:03:48Z","timestamp":1374008628000},"page":"e68969","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":24,"title":["Successful Human Infection with P. falciparum Using Three Aseptic Anopheles stephensi Mosquitoes: A New Model for Controlled Human Malaria Infection"],"prefix":"10.1371","volume":"8","clinical-trial-number":[{"clinical-trial-number":"nct00744133","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Matthew B.","family":"Laurens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Billingsley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Richman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abraham G.","family":"Eappen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Adams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumana","family":"Chakravarty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anusha","family":"Gunasekera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher G.","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. Kim Lee","family":"Sim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Edelman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher V.","family":"Plowe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen L.","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsten E.","family":"Lyke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,7,16]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4269\/ajtmh.1986.35.66","article-title":"Malaria transmitted to humans by mosquitoes infected from cultured Plasmodium falciparum","volume":"35","author":"JD Chulay","year":"1986","journal-title":"Am J Trop Med Hyg"},{"key":"ref2","first-page":"124","article-title":"A model for Plasmodium falciparum sporozoite challenge and very early therapy of parasitaemia for efficacy studies of sporozoite vaccines","volume":"40","author":"DA Herrington","year":"1988","journal-title":"Trop Geogr Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0140-6736(87)90540-X","article-title":"Safety and efficacy of a recombinant DNA Plasmodium falciparum sporozoite vaccine","volume":"1","author":"WR Ballou","year":"1987","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/328257a0","article-title":"Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites","volume":"328","author":"DA Herrington","year":"1987","journal-title":"Nature"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"831","DOI":"10.4269\/ajtmh.1999.60.831","article-title":"Prophylactic activity of atovaquone against Plasmodium falciparum in humans","volume":"60","author":"TA Shapiro","year":"1999","journal-title":"Am J Trop Med Hyg"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1086\/513990","article-title":"Clinical manifestations of Plasmodium falciparum malaria experimentally induced by mosquito challenge","volume":"175","author":"LW Church","year":"1997","journal-title":"J Infect Dis"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1086\/518510","article-title":"Safety and clinical outcome of experimental challenge of human volunteers with Plasmodium falciparum-infected mosquitoes: an update","volume":"196","author":"JE Epstein","year":"2007","journal-title":"J Infect Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1086\/318534","article-title":"Efficacy of recombinant circumsporozoite protein vaccine regimens against experimental Plasmodium falciparum malaria","volume":"183","author":"KE Kester","year":"2001","journal-title":"J Infect Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"5359","DOI":"10.1016\/j.vaccine.2007.05.005","article-title":"A phase I\/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS,S\/AS02A in malaria-naive adults","volume":"25","author":"KE Kester","year":"2007","journal-title":"Vaccine"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1016\/j.vaccine.2008.02.048","article-title":"Phase 2a trial of 0, 1, and 3 month and 0, 7, and 28 day immunization schedules of malaria vaccine RTS,S\/AS02 in malaria-naive adults at the Walter Reed Army Institute of Research","volume":"26","author":"KE Kester","year":"2008","journal-title":"Vaccine"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1086\/600120","article-title":"Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S\/AS01B and RTS,S\/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection","volume":"200","author":"KE Kester","year":"2009","journal-title":"J Infect Dis"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/S0140-6736(10)60601-0","article-title":"Malaria 2010: more ambition and accountability please","volume":"375","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"5719","DOI":"10.1016\/j.vaccine.2009.07.049","article-title":"Report of a consultation on the optimization of clinical challenge trials for evaluation of candidate blood stage malaria vaccines, 18\u201319 March 2009, Bethesda, MD, USA","volume":"27","author":"VS Moorthy","year":"2009","journal-title":"Vaccine"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Laurens MB, Roestenberg M, Moorthy VS (2012) A consultation on the optimization of controlled human malaria infection by mosquito bite for evaluation of candidate malaria vaccines. Vaccine. 10.1016\/j.vaccine.2012.04.088 [doi].","DOI":"10.1016\/j.vaccine.2012.04.088"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Driver JR, Gammel JA, Darnosh LJ (1926) Malaria treatment central nervous system \u201csyphilis\u201d. Journal of the American Medical Association (lxxxvii), 1921, Cited in Bunker \u2018Recent treatment of general paralysis\u2019.","DOI":"10.1001\/jama.1926.02680220037009"},{"key":"ref16","first-page":"371","article-title":"Why Wagner-Juaregg won the Nobel Prize for discovering Malaria Therapy for General Paresis of the Insane","volume":"xi","author":"EM Brown","year":"2000","journal-title":"Journal of Psychiatry"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00000441-197309000-00002","article-title":"Immunization of man against sporozite-induced falciparum malaria","volume":"266","author":"DF Clyde","year":"1973","journal-title":"Am J Med Sci"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/0035-9203(74)90129-1","article-title":"Letter: Sporozoite induced immunity in man against an Ethiopian strain of Plasmodium falciparum","volume":"68","author":"KH Rieckmann","year":"1974","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nri2902","article-title":"Experimental human challenge infections can accelerate clinical malaria vaccine development","volume":"11","author":"RW Sauerwein","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1017\/S0022172400042558","article-title":"The laboratory transmission of Coxsackie A6 virus by mosquitoes","volume":"68","author":"T Maguire","year":"1970","journal-title":"J Hyg (Lond)"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.vetmic.2009.08.025","article-title":"Zoonotic mosquito-borne flaviviruses: worldwide presence of agents with proven pathogenicity and potential candidates of future emerging diseases","volume":"140","author":"H Weissenbock","year":"2010","journal-title":"Vet Microbiol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"e13490","DOI":"10.1371\/journal.pone.0013490","article-title":"Plasmodium falciparum malaria challenge by the bite of aseptic Anopheles stephensi mosquitoes: results of a randomized infectivity trial","volume":"5","author":"KE Lyke","year":"2010","journal-title":"PLoS One"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Epstein JE, Tewari K, Lyke KE, Sim BK, Billingsley PF, <etal>et al<\/etal>.. (2011) Live attenuated malaria vaccine designed to protect through hepatic CD8 T cell immunity. Science 334: 475\u2013480. science. 10.1126\/science.1211548 [doi].","DOI":"10.1126\/science.1211548"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0140-6736(08)60418-3","article-title":"Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I Follow-up Study cohort","volume":"371","author":"TA Gaziano","year":"2008","journal-title":"Lancet"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4161\/hv.6.1.10396","article-title":"Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria","volume":"6","author":"SL Hoffman","year":"2010","journal-title":"Hum Vaccin"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/1475-2875-8-277","article-title":"Cardiac complication after experimental human malaria infection: a case report","volume":"8","author":"AE Nieman","year":"2009","journal-title":"Malar J"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"e5254","DOI":"10.1371\/journal.pone.0005254","article-title":"Phase 1\/2a study of the malaria vaccine candidate apical membrane antigen-1 (AMA-1) administered in adjuvant system AS01B or AS02A","volume":"4","author":"MD Spring","year":"2009","journal-title":"PLoS ONE"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1126\/science.3672135","article-title":"Structurally distinct, stage-specific ribosomes occur in Plasmodium","volume":"238","author":"JH Gunderson","year":"1987","journal-title":"Science"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1086\/427243","article-title":"Calculation of liver-to-blood inocula, parasite growth rates, and preerythrocytic vaccine efficacy, from serial quantitative polymerase chain reaction studies of volunteers challenged with malaria sporozoites","volume":"191","author":"P Bejon","year":"2005","journal-title":"J Infect Dis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"e38434","DOI":"10.1371\/journal.pone.0038434","article-title":"Comparison of clinical and parasitological data from controlled human malaria infection trials","volume":"7","author":"M Roestenberg","year":"2012","journal-title":"PLoS One"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1098\/rspb.1910.0075","article-title":"Some Enumerative Studies on Malaria Fever","volume":"83","author":"R Ross","year":"1910","journal-title":"Proc R Soc Lond"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0035-9203(00)90300-6","article-title":"Severe falciparum malaria. Communicable Diseases Cluster","volume":"94","year":"2000","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S1286-4579(00)00362-2","article-title":"The journey of the malaria sporozoite through its hosts: two parasite proteins lead the way","volume":"2","author":"R Menard","year":"2000","journal-title":"Microbes Infect"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/00034983.1959.11685899","article-title":"Early activity in sporozoite-induced Plasmodium falciparum infections","volume":"53","author":"GM Jeffery","year":"1959","journal-title":"Ann Trop Med Parasitol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1128\/AAC.34.4.676","article-title":"Continuation of chloroquine-susceptible Plasmodium falciparum parasitemia in volunteers receiving chloroquine therapy","volume":"34","author":"JR Murphy","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/1475-2875-10-219","article-title":"Reduction in host-finding behaviour in fungus-infected mosquitoes is correlated with reduction in olfactory receptor neuron responsiveness","volume":"10","author":"J George","year":"2011","journal-title":"Malar J"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1126\/science.1108423","article-title":"Fungal pathogen reduces potential for malaria transmission","volume":"308","author":"S Blanford","year":"2005","journal-title":"Science"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0166-6851(00)00387-X","article-title":"Bacteria expressing single-chain immunotoxin inhibit malaria parasite development in mosquitoes","volume":"113","author":"S Yoshida","year":"2001","journal-title":"Mol Biochem Parasitol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"4363","DOI":"10.1128\/IAI.73.7.4363-4369.2005","article-title":"Quantitative dynamics of Plasmodium yoelii sporozoite transmission by infected anopheline mosquitoes","volume":"73","author":"DL Medica","year":"2005","journal-title":"Infect Immun"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1128\/IAI.66.8.3783-3787.1998","article-title":"Only viable parasites are detected by PCR following clearance of rodent malarial infections by drug treatment or immune responses","volume":"66","author":"W Jarra","year":"1998","journal-title":"Infect Immun"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/0169-4758(95)80132-4","article-title":"The cytoplasmic ribosomal RNAs of Plasmodium spp","volume":"11","author":"TF McCutchan","year":"1995","journal-title":"Parasitol Today"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0035-9203(01)90016-1","article-title":"Genesis, sequestration and survival of Plasmodium falciparum gametocytes: parameter estimates from fitting a model to malariatherapy data","volume":"95","author":"M Eichner","year":"2001","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"366","DOI":"10.4269\/ajtmh.2003.68.366","article-title":"A retrospective examination of mosquito infection on humans infected with Plasmodium falciparum","volume":"68","author":"WE Collins","year":"2003","journal-title":"Am J Trop Med Hyg"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1645\/GE-1052R.1","article-title":"Gametocytemia and fever in human malaria infections","volume":"93","author":"FE McKenzie","year":"2007","journal-title":"J Parasitol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"191","DOI":"10.4269\/ajtmh.2005.73.191","article-title":"Quantitative real-time polymerase chain reaction for malaria diagnosis and its use in malaria vaccine clinical trials","volume":"73","author":"L Andrews","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1475-2875-5-104","article-title":"Thick blood film examination for Plasmodium falciparum malaria has reduced sensitivity and underestimates parasite density","volume":"5","author":"P Bejon","year":"2006","journal-title":"Malar J"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1475-2875-10-48","article-title":"A real-time, quantitative PCR method using hydrolysis probes for the monitoring of Plasmodium falciparum load in experimentally infected human volunteers","volume":"10","author":"RJ Rockett","year":"2011","journal-title":"Malar J"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"7514","DOI":"10.1016\/j.vaccine.2011.03.083","article-title":"A human Phase I\/IIa malaria challenge trial of a polyprotein malaria vaccine","volume":"29","author":"DW Porter","year":"2011","journal-title":"Vaccine"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"e1493","DOI":"10.1371\/journal.pone.0001493","article-title":"Evidence of blood stage efficacy with a virosomal malaria vaccine in a phase IIa clinical trial","volume":"3","author":"FM Thompson","year":"2008","journal-title":"PLoS One"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"196","DOI":"10.4269\/ajtmh.2004.71.2.0700196","article-title":"Testing vaccines in human experimental malaria: statistical analysis of parasitemia measured by a quantitative real-time polymerase chain reaction","volume":"71","author":"CC Hermsen","year":"2004","journal-title":"Am J Trop Med Hyg"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1016\/S0140-6736(11)60360-7","article-title":"Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study","volume":"377","author":"M Roestenberg","year":"2011","journal-title":"Lancet"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1475-2875-4-21","article-title":"Expression of Plasmodium falciparum erythrocyte membrane protein 1 in experimentally infected humans","volume":"4","author":"T Lavstsen","year":"2005","journal-title":"Malar J"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4049\/jimmunol.179.1.162","article-title":"Plasmodium falciparum infection causes proinflammatory priming of human TLR responses","volume":"179","author":"MB McCall","year":"2007","journal-title":"J Immunol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1056\/NEJMoa0805832","article-title":"Protection against a malaria challenge by sporozoite inoculation","volume":"361","author":"M Roestenberg","year":"2009","journal-title":"N Engl J Med"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4269\/ajtmh.2012.12-0613","article-title":"Controlled human malaria infections by intradermal injection of cryopreserved Plasmodium falciparum sporozoites","volume":"88","author":"M Roestenberg","year":"2013","journal-title":"Am J Trop Med Hyg"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0068969","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,30]],"date-time":"2020-07-30T23:54:18Z","timestamp":1596153258000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0068969"}},"subtitle":[],"editor":[{"given":"Aric","family":"Gregson","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,7,16]]},"references-count":55,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2013,7,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0068969","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,16]]}}}